Women who miss their first mammogram face a 40 per cent higher risk of dying from breast cancer over 25 years, mainly because cancers are detected...
The UK’s first pink duck race has raised thousands for breast cancer support after 5,000 rubber ducks floated down Cambridge’s River Cam. Each duck represented a...
The financial impact of breast cancer on the UK economy is projected to rise by nearly a third to £4.2bn within 25 years, new analysis warns....
AI is increasingly being leveraged to address challenges in breast cancer care, from a “second set of eyes” during screening to enabling more personalised treatments. Innovators...
Lobular breast cancer affects 15 per cent of patients but rarely forms lumps, meaning symptoms are often missed or misdiagnosed until later stages, experts have warned....
Around 5,700 breast cancer patients will now be eligible for ribociclib after NICE widened access to the combination therapy. Ribociclib will be available on the NHS...
Targeted radiotherapy is as effective as full-breast treatment for low-risk breast cancer but causes fewer side effects, a decade-long UK study has found. Partial-breast radiotherapy, which...
Mounjaro may significantly reduce breast cancer tumour growth in obese patients, according to early-stage research in mice. The weight loss drug, which contains tirzepatide, showed what...
Femtech World explores the latest developments in women’s health research – from overcoming EGFR-targeted therapy resistance in breast cancer to understanding obesity’s role in triple-negative breast...
New research suggests that one in three eligible women in the US skip recommended mammograms – leading to late-stage breast cancer diagnosis, doubling treatment costs and...
